Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.77B | $10.4B | $10.8B | $11.4B | $11.6B | $12.6B | $13.4B | $14.3B | $15.8B | $17.4B |
| Revenue growth | — | 6.6% | 3.5% | 5.6% | 1.6% | 9.4% | 6.0% | 6.6% | 10.8% | 9.7% |
| Operating income | $1.28B | $1.28B | $1.18B | $1.22B | $1.36B | $1.36B | $1.00B | $1.18B | $1.68B | $1.99B |
| Operating margin | 13.1% | 12.3% | 10.9% | 10.7% | 11.8% | 10.8% | 7.5% | 8.2% | 10.6% | 11.5% |
| Net income | $702M | $752M | $780M | $815M | $944M | $992M | $676M | $718M | $1.14B | $1.49B |
| Net margin | 7.2% | 7.2% | 7.2% | 7.2% | 8.2% | 7.8% | 5.0% | 5.0% | 7.2% | 8.6% |
| EPS (diluted) | $7.14 | $7.81 | $8.31 | $9.13 | $10.99 | $11.82 | $9.14 | $10.23 | $16.82 | $23.10 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.33B | $1.25B | $1.27B | $1.44B | $2.36B | $884M | $996M | $1.27B | $2.07B | $1.86B |
| Capital expenditures | $520M | $558M | $665M | $634M | $731M | $856M | $734M | $743M | $944M | $1.02B |
| Free cash flow | $814M | $690M | $610M | $804M | $1.63B | $28.0M | $262M | $525M | $1.12B | $849M |
| Share buybacks | $353M | $364M | $397M | $771M | $207M | $1.22B | $833M | $547M | $671M | $968M |
| Dividends paid | $38.9M | $38.2M | $37.3M | $53.0M | $17.3M | $65.9M | $58.4M | $55.5M | $53.3M | $51.3M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $33.7M | $74.4M | $105M | $61.3M | $1.22B | $115M | $103M | $119M | $126M | $138M |
| Total assets | $10.3B | $10.8B | $11.3B | $11.7B | $13.5B | $13.1B | $13.5B | $14.0B | $14.5B | $15.5B |
| Long-term debt | $4.03B | $3.49B | $3.94B | $3.90B | $3.52B | $4.14B | $4.73B | $4.79B | $4.46B | $4.00B |
| Shareholders' equity | $4.53B | $4.99B | $5.39B | $5.50B | $6.32B | $6.09B | $5.92B | $6.15B | $6.67B | $7.28B |
| Retained earnings | $4.89B | $5.35B | $5.79B | $5.93B | $6.75B | $6.60B | $6.53B | $6.80B | $7.37B | $7.99B |
| Shares (wtd avg diluted) | 98.4M | 96.3M | 93.8M | 89.0M | 85.6M | 83.7M | 73.8M | 70.1M | 67.9M | 64.5M |
Every figure is extracted from UNIVERSAL HEALTH SERVICES INC’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.